Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?

Adjuvant chemotherapy aims at eradicating tumour cells sometimes present after radical surgery for a colorectal cancer (CRC) and thereby diminish the recurrence rate and prolong time to recurrence (TTR). Remaining tumour cells will lead to recurrent disease that is usually fatal. Adjuvant therapy is...

Full description

Bibliographic Details
Main Authors: Erik Osterman, Klara Hammarström, Israa Imam, Emerik Osterlund, Tobias Sjöblom, Bengt Glimelius
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
colorectal cancer
colon cancer
rectal cancer
chemotherapy
adjuvant treatment
recurrence risk
Online Access:https://www.mdpi.com/2072-6694/12/11/3308

Similar Items

Similar Items